A Cure for Cancer? How CAR T-Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
Update (14/01/2019): An anonymous French company on Euronext has made an offer to take over…
Our very own red blood cells could soon become a treatment for some of the…
Celyad has reported clinical results showing the first time a patient has fully recovered from…
This week, we're in Barcelona, Spain, to visit Leukos Biotech, whose goal is to develop…
Genmab's leukemia drug will be available around the world through compassionate use programs, while it will…
Data presented at ASH 2017 shows that Servier and Pfizer's UCART19, an allogeneic CAR-T therapy…
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
Kiadis Pharma starts Phase III trials with ATIR101, a therapy that could make half-matched donors…
Update (15/11/2017): Erytech has closed its Nasdaq IPO raising a total of $144M (€122M) despite…
UPDATE: The FDA has lifted both clinical holds provided that Cellectis decreases the dose of…
Gilead's CAR-T cell therapy Yescarta has been approved by the FDA, making it the first…